Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07437638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2026 (before its estimated April 5, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study aims to develop a practical tool for identifying cirrhotic patients at high risk of hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS) placement. A retrospective analysis will be conducted on medical records of 624 cirrhotic patients who underwent TIPS from 2011 to 2021. Statistical methods will be applied to screen preoperative routine indicators associated with post-TIPS hepatic encephalopathy risk. A predictive nomogram will be constructed incorporating the screened indicators to estimate individual preoperative risk. The predictive performance will be compared with conventional clinical scoring systems. This tool is intended to facilitate preoperative risk evaluation and targeted management of high-risk patients undergoing TIPS
Trial Details
NCT Number NCT07437638
Lead Sponsor The Second Affiliated Hospital of Chongqing Medical University
Conditions
(from sponsor)		 Liver Cirrhosis, Hepatic Encephalopathy, TIPS
Related terms Fibrosis, Hepatic Encephalopathy, Liver Cirrhosis
Enrollment 624 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov